Trial Profile
A study evaluating characteristics of patients initiating glucose lowering drugs in the United Kingdom.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jul 2017
Price :
$35
*
At a glance
- Drugs Empagliflozin (Primary) ; Dipeptidyl peptidase 4 inhibitors; Metformin; Sodium-glucose transporter 2 inhibitors; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 19 Jul 2017 New trial record
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association